Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Cannabis Product Infusion and Formulation

Active

State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract titled Cannabis Product Infusion and Formulation is a subcontract under the City of Los Angeles, targeting the precise infusion of cannabis extracts into consumer products such as edibles, tinctures, and topicals, with strict adherence to dosing accuracy and regulatory compliance. The work is performance-based and must meet industry standards for quality, consistency, and safety within the regulated cannabis market. The place of performance is designated as Los Angeles, California, with a zip code of 90021, indicating that all operations, including formulation, testing, and packaging, must occur within this localized jurisdiction to align with municipal and state cannabis regulations. The NAICS code 325412 classifies the contract under Pharmaceutical and Medicine Manufacturing, emphasizing the technical and scientific rigor required for product development. The solicitation was posted on July 31, 2026, and while it does not specify a set-aside type or organizational preference, the focus on precision infusion implies a need for specialized expertise in extraction chemistry, dosage control, and Good Manufacturing Practices. The absence of a point of contact or detailed solicitation number suggests this may be an open or pre-qualified subcontract opportunity, with all activity tied to compliance with California’s legal cannabis framework and Los Angeles municipal ordinances.

General Info

Cannabis infusion contract in Los Angeles for edibles, tinctures, topicals with strict dosing and regulatory compliance.

Agency

California → City of Los Angeles

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Los Angeles, CA, 90021

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 31

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyCalifornia → City of Los Angeles

ContactsNo contacts available

OfficeN/A

Organization / Agency

California → City of Los Angeles

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Infusing cannabis extracts into edibles, tinctures, topicals, and other consumer products requiring precise dosing and compliance.

Similar Contracts

Same NAICS industry code

Flu Vaccine Supply (Flucelvax Trivalent)The contract entails the supply of 2,000 units of FDA-approved Flucelvax Trivalent vaccine in 0.5 ml pre-filled single-dose syringes without needles, specifically for vaccination of the National Geospatial-Intelligence Agency workforce. The vaccine is intended for seasonal influenza prevention and must meet all regulatory standards for safety and efficacy as defined by the FDA. Delivery is required to be performed at the designated place of performance in Springfield, with all units shipped in compliant, ready-to-administer packaging. The contract is classified as a subcontract under NAICS code 325412, which corresponds to pharmaceutical preparation manufacturing. The solicitation was posted on July 31, 2026, and responses are due by August 10, 2026, at 10:00 PM Eastern Time. The contracting entity is the Department of Defense through the National Geospatial-Intelligence Agency, and no set-aside provisions are indicated, meaning the opportunity is open to all qualified vendors regardless of business size or ownership status.

National Geospatial-Intelligence Agency

POSTED

DEADLINE

Flu Vaccines and Associated Supplies

Solicitation # HM047626Q0030

The solicitation for Flu Vaccines and Associated Supplies under HM047626Q0030 has been amended to remove the clause 52.219-6 NOTICE OF TOTAL SMALL BUSINESS SET-ASIDE, indicating the procurement is no longer restricted to small businesses. The government has also provided responses to questions received from potential offerors, with the full Q&A attached for reference. The deadline for submitting proposals has been extended to 5:00 p.m. Central Time on August 10, 2026, and all proposal submission requirements have been updated accordingly to reflect this new date. All other terms and conditions of the original solicitation remain in effect. The award will be made to the responsible offeror submitting the lowest price technically acceptable quote, as determined by the LPTA evaluation method. Offerors must review the full solicitation document and Statement of Work, and submit a completed quote sheet as required. The contracting activity is managed by the National Geospatial-Intelligence Agency under the Department of Defense, with the primary point of contact being Kathleen Dee at the provided email and phone number. The place of performance is in Springfield, Virginia, while the issuing office is located in Arnold, Missouri.

National Geospatial-Intelligence Agency

POSTED

DEADLINE

Supply of Vitamin and Mineral Fortified BlendsThe contract pertains to the production and supply of micronutrient-fortified nutritional blends designed to combat vitamin and mineral deficiencies within clinical environments. These products are intended for use in healthcare settings to support patient recovery and nutritional adequacy, particularly in populations at risk of deficiencies. The work is classified under NAICS code 325412, indicating manufacturing of pharmaceutical and botanical products, and is structured as a subcontract, suggesting it is part of a larger procurement effort led by the South East Regional Health Authority under the Government of Jamaica. The solicitation was posted on July 30, 2026, and performance is expected to occur within Jamaica, though specific location details are not provided. The contract does not specify a set-aside designation or point of contact, indicating that further details may be obtained through the provided government portal link.

South East Regional Health Authority

POSTED

DEADLINE

Pharmaceutical Supply – Bupivacaine and Epinephrine InjectionThe contract is for the supply of two cartons of Bupivacaine and Epinephrine Injection, each containing 50 cartridges of 1.8 mL, with a concentration of 0.500% w/v Bupivacaine HCl and 0.005 mg Epinephrine per mL, adhering to strict FDA and military medical marking requirements. The药品 must meet all applicable regulatory and military standards to ensure compatibility and safety within defense medical operations. The solicitation is classified as a subcontract under NAICS code 325412, issued by the Department of Defense through the Medical Supply Chain Pharm FSA, with performance required in San Diego, CA, 92136. The opportunity was posted on July 30, 2026, and responses must be submitted by August 5, 2026, with all bids expected to comply with the specified product configuration, packaging, and labeling protocols mandated for military use.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Ultrasound Transmission Gel Manufacturing and FormulationThe contract seeks a manufacturer to produce a medical-grade ultrasound transmission gel that is tinted and viscous, formulated as an aqueous solution meeting stringent specifications for pH, viscosity, and a minimum shelf life of 60 months. The gel must be safe for direct skin contact and compatible with ultrasound transducers, ensuring optimal acoustic coupling while maintaining integrity over extended storage periods. All production processes and final product quality must adhere to medical-grade standards, with rigorous controls to guarantee consistency, sterility, and absence of harmful contaminants. Performance of this subcontract is tied to Fort Bragg, North Carolina, with a response deadline of August 6, 2026, following a posting date of July 30, 2026, under the NAICS code 325412 for pharmaceutical and botanical manufacturing. The contracting entity operates under the Department of Defense, specifically within the Medical Supply Chain FSH, indicating this is a defense-related procurement likely intended for military medical facilities. No set-aside information is provided, and submissions must align precisely with technical requirements for composition, labeling, packaging, and documentation to be considered for award.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Pharmaceutical Manufacturing – Tolnaftate Powder (USP 1%)The contract calls for the manufacture of Tolnaftate Powder, USP 1%, in 45-gram units, adhering strictly to United States Pharmacopeia standards, Good Manufacturing Practices, and applicable military specifications. Production must include comprehensive batch testing and rigorous quality control measures to ensure consistency, purity, and potency throughout the manufacturing process. All units must meet exacting pharmaceutical and defense-grade requirements, with full traceability and documentation to support regulatory compliance and operational readiness. The solicitation is classified as a subcontract under NAICS code 325412, issued by the Department of Defense through the Medical Supply Chain Pharm FSA. The place of performance is designated as FPO with ZIP code 09570, indicating delivery to a military postal address. The response deadline is August 5, 2026, with the solicitation posted on July 30, 2026, leaving a limited window for qualified manufacturers to submit proposals. While no specific set-aside status or point of contact is provided, interested parties must reference the official DIBBS portal link to access full solicitation details and ensure compliance with all submission requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Dental Bonding Agent SupplyThe contract involves the supply and delivery of a commercial off-the-shelf dental bonding agent known as the Ultra-Etch 4PK Kit, which includes viscous 35% phosphoric acid gel, syringes, and micro tips, all packaged and labeled to meet federal and military compliance standards. The product must be shipped in accordance with strict regulatory requirements to ensure safety, efficacy, and readiness for use in military medical environments. The solicitation is issued under the NAICS code 325412, which corresponds to pharmaceutical and medicine manufacturing, and is managed by the Department of Defense through the Medical Supply Chain FSH. The place of performance is specified as Suffolk, Virginia, with a zip code of 23435-5000, indicating where the delivered goods will be received and utilized. The solicitation was posted on July 30, 2026, with a response deadline of August 6, 2026, giving potential suppliers just one week to submit their proposals. This is structured as a subcontract opportunity, meaning it is likely part of a larger procurement effort, and no specific set-aside classification has been designated, indicating it is open to all eligible contractors regardless of business size or category. The contract is accessible via the DIBBS platform, which is the Department of Defense’s official system for managing procurement actions, and all submissions must comply with the technical, logistical, and regulatory demands outlined to ensure seamless integration into military dental care protocols.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Dental Calcium Hydroxide Paste Manufacturing & SupplyThe contract calls for the manufacture and supply of a radiopaque, antibacterial calcium hydroxide paste specifically designed for dental endodontic applications, with strict adherence to FDA and DLA specifications. The scope encompasses the full lifecycle of the product including formulation development, packaging, labeling, and compliance with safety data sheet requirements to ensure regulatory and clinical suitability. The product must meet precise technical standards to function effectively in root canal treatments, combining radiopacity for accurate imaging with antibacterial properties to inhibit microbial growth. Performance is designated to occur in Suffolk, Virginia, with a response deadline of August 6, 2026, and the solicitation is classified as a subcontract under NAICS code 325412 for pharmaceutical and cosmetic manufacturing. The contracting organization is the Department of Defense through its Medical Supply Chain FSH unit, indicating this is a defense-related procurement aimed at equipping military dental services. All materials and processes must align with federal procurement and quality control mandates, and submission is managed through the DLA’s DIBBS platform.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Pharmaceutical Manufacturing and SupplyThe contract pertains to the manufacture and supply of Erythromycin Ophthalmic Ointment, USP, adhering to all applicable FDA regulations, current good manufacturing practices, and specific labeling requirements set forth by the Defense Logistics Agency. The product must be assigned the National Drug Code NDC 00574-4024-39 and meet stringent quality and compliance standards to ensure safety and efficacy for military and federal healthcare use. Production and delivery are to be executed in compliance with cGMP guidelines and DLA labeling protocols, ensuring traceability and regulatory alignment throughout the supply chain. This subcontract, categorized under NAICS code 325412 for pharmaceutical and medicine manufacturing, is issued by the Department of Defense through the Medical Supply Chain Pharm FSA. The place of performance is designated as Fort Lewis, WA, with a zip code of 98433-9500. The solicitation was posted on July 30, 2026, and responses are due by August 5, 2026, indicating a narrow five-day window for submission. Interested parties must submit proposals through the official DIBBS portal linked in the contract details, as no point of contact information is provided and all communications will be handled through the designated procurement system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supplier – BenzoCaine and Menthol LozengesThe contract calls for the supply of six units of CHLORASEPTIC MAX lozenges, each containing 15 mg of benzocaine and 10 mg of menthol, to meet stringent FDA, OSHA, and Department of Defense packaging and labeling requirements. The deliverables must comply with all regulatory standards for pharmaceutical products intended for military and federal use, ensuring safe handling, accurate identification, and proper storage conditions. The solicitation is classified as a subcontract under NAICS code 325412, indicating it falls within the pharmaceutical and medicine manufacturing sector, and is managed by the Department of Defense through the Medical Supply Chain Pharm FSA. Responses are due by August 5, 2026, with the solicitation posted on July 30, 2026, providing a limited window for potential suppliers to prepare and submit proposals. The place of performance is designated as Ellsworth Air Force Base, South Dakota, with a zip code of 57706-4821, indicating the final destination for the lozenges. Although the solicitation number and point of contact details are not provided in the data, the official record is accessible through the DIBBS platform at the specified URL. All parties must adhere to DoD procurement protocols, including documentation, quality assurance, and delivery timelines to meet operational readiness needs.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supply – Dextrose Injection 5% (NSN 6505013306252)The contract requires the supply and delivery of Dextrose Injection 5%, USP, 1000 mL, in 12-unit cases, in full compliance with U.S. Pharmacopeial standards and the Defense Logistics Agency’s technical specifications. The product, identified by NSN 6505013306252, is intended for federal medical use and must meet stringent quality, packaging, and labeling requirements to ensure safety and efficacy. Performance is to be executed at the FPO mail facility with ZIP code 96669, reflecting the logistical nature of military medical supply distribution. The solicitation, issued under the NAICS code 325412 for pharmaceutical preparation manufacturing, is structured as a subcontract opportunity managed by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA. Responses are due by August 5, 2026, with the solicitation posted on July 30, 2026, providing a seven-day window for interested vendors to submit proposals through the DIBBS platform.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Sterile Pharmaceutical Manufacturing (WATER FOR INJECTION, USP)The contract pertains to the manufacture and packaging of sterile water for injection in 1000mL plastic bags, strictly adhering to USP, FDA, and DLA standards to ensure pharmaceutical quality and safety. The product must be produced under controlled sterile conditions and meet all regulatory requirements for parenteral use, with packaging in compliant plastic bags that maintain sterility and integrity throughout distribution and use. The work is designated as a subcontract under NAICS code 325412, specifically for pharmaceutical manufacturing, and is tied to the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation was posted on July 30, 2026, with a response deadline of August 5, 2026, indicating a tight turnaround for qualified manufacturers to submit proposals. Performance of the contract is required at Fort Bragg, North Carolina, with a zip code of 28310, suggesting direct logistical coordination with military medical supply operations. The contract does not specify a set-aside type, meaning it is open to all eligible subcontractors regardless of business size or ownership status. All submissions must align with the defense supply chain’s stringent quality and compliance protocols to support critical medical needs within the DoD healthcare system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE